S&P 500   3,204.62 (-0.68%)
DOW   26,779.53 (-0.34%)
S&P 500   3,204.62 (-0.68%)
DOW   26,779.53 (-0.34%)
S&P 500   3,204.62 (-0.68%)
DOW   26,779.53 (-0.34%)
S&P 500   3,204.62 (-0.68%)
DOW   26,779.53 (-0.34%)
Log in

NYSE:VARVarian Medical Systems Stock Price, Forecast & News

$126.60
+0.43 (+0.34 %)
(As of 07/16/2020 10:26 AM ET)
Add
Compare
Today's Range
$124.97
Now: $126.60▼
$126.60
50-Day Range
$113.25
MA: $121.18▼
$132.37
52-Week Range
$89.62
Now: $126.60▼
$150.06
Volume1,315 shs
Average Volume599,749 shs
Market Capitalization$11.50 billion
P/E Ratio46.54
Dividend YieldN/A
Beta1.07
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions; and a strategic cooperation framework agreement with Shandong Cancer Hospital for proton therapy clinical application and research in China. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.
Read More
Varian Medical Systems logo

Beat the Market (BTM) Rank™

Analyst Opinion: 2.2Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.55 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSE
Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNYSE:VAR
Previous Symbol
CUSIP92220P10
CIK203527
Webwww.varian.com
Phone650-493-4000

Debt

Debt-to-Equity Ratio0.05
Current Ratio1.28
Quick Ratio0.97

Price-To-Earnings

Trailing P/E Ratio46.54
Forward P/E Ratio35.17
P/E Growth4.22

Sales & Book Value

Annual Sales$3.23 billion
Price / Sales3.57
Cash Flow$5.92 per share
Price / Cash Flow21.37
Book Value$19.52 per share
Price / Book6.49

Profitability

EPS (Most Recent Fiscal Year)$4.63
Net Income$291.90 million
Net Margins7.51%
Return on Equity22.93%
Return on Assets9.88%

Miscellaneous

Employees10,062
Outstanding Shares90,820,000
Market Cap$11.50 billion
Next Earnings Date7/22/2020 (Estimated)
OptionableOptionable
VAR Rates by TradingView

Receive VAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VAR and its competitors with MarketBeat's FREE daily newsletter.

Varian Medical Systems (NYSE:VAR) Frequently Asked Questions

How has Varian Medical Systems' stock been impacted by COVID-19 (Coronavirus)?

Varian Medical Systems' stock was trading at $113.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, VAR shares have increased by 11.0% and is now trading at $125.52. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Varian Medical Systems?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 2 sell ratings, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Varian Medical Systems.

When is Varian Medical Systems' next earnings date?

Varian Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Varian Medical Systems.

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) announced its quarterly earnings results on Monday, May, 4th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.85. The medical equipment provider had revenue of $794.50 million for the quarter, compared to the consensus estimate of $769.99 million. Varian Medical Systems had a return on equity of 22.93% and a net margin of 7.51%. Varian Medical Systems's revenue was up 1.9% compared to the same quarter last year. During the same quarter last year, the business posted $1.05 EPS. View Varian Medical Systems' earnings history.

What price target have analysts set for VAR?

8 brokers have issued 1 year price objectives for Varian Medical Systems' shares. Their forecasts range from $90.00 to $150.00. On average, they expect Varian Medical Systems' share price to reach $125.25 in the next twelve months. This suggests that the stock has a possible downside of 0.2%. View analysts' price targets for Varian Medical Systems.

What are Wall Street analysts saying about Varian Medical Systems stock?

Here are some recent quotes from research analysts about Varian Medical Systems stock:
  • 1. According to Zacks Investment Research, "Varian continues to gain from its core Oncology Systems segment, which saw solid overseas growth, especially in EMEA and China. In fact, management foresees tremendous opportunities in China owing to the recent tariff exclusions. Gross orders surged in the quarter. Management is optimistic about the recently-closed acquisitions of CyberHeart, Cancer Treatment Services International, Endocare and Alicon. Expansion in gross margin is an added positive. Varian retained its outlook for fiscal 2020. On the flip side, the Proton Solutions unit was weak in the quarter. Moreover, Varian saw some softness in orders in Japan. Economic stagnation due to coronavirus outbreak has been another dampener. Reflective of these, the stock has underperformed the industry in a year’s time. Varian exited the fiscal first quarter on a weak note." (4/10/2020)
  • 2. Barrington Research analysts commented, "We strongly suspect that radiation that is delivered via the Ethos system will receive very high marks from both clinicians and patients alike. Ethos currently has its CE Mark while a 510(k) regulatory clearance in the U.S. is still pending." (9/23/2019)

Has Varian Medical Systems been receiving favorable news coverage?

Headlines about VAR stock have been trending positive recently, according to InfoTrie. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Varian Medical Systems earned a news sentiment score of 2.1 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View the latest news about Varian Medical Systems.

Are investors shorting Varian Medical Systems?

Varian Medical Systems saw a increase in short interest in June. As of June 30th, there was short interest totaling 3,650,000 shares, an increase of 11.6% from the June 15th total of 3,270,000 shares. Based on an average daily trading volume, of 809,300 shares, the short-interest ratio is presently 4.5 days. Currently, 4.0% of the shares of the stock are sold short. View Varian Medical Systems' Current Options Chain.

Who are some of Varian Medical Systems' key competitors?

What other stocks do shareholders of Varian Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varian Medical Systems investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Netflix (NFLX), AT&T (T), Thermo Fisher Scientific (TMO), Visa (V), Align Technology (ALGN), Intel (INTC), Pfizer (PFE) and Verizon Communications (VZ).

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the following people:
  • Mr. Dow R. Wilson, Pres, CEO & Director (Age 60)
  • Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 51)
  • Mr. John W. Kuo, Sr. VP, Gen. Counsel & Corp. Sec. (Age 56)
  • Ms. Kolleen T. Kennedy, Chief Growth Officer & Pres of Proton Solutions (Age 60)
  • Mr. Kevin O'Reilly, Sr. VP of Global Operations

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

Who are Varian Medical Systems' major shareholders?

Varian Medical Systems' stock is owned by a number of institutional and retail investors. Top institutional investors include Envestnet Asset Management Inc. (0.09%), JLB & Associates Inc. (0.08%), State of Alaska Department of Revenue (0.06%), DNB Asset Management AS (0.02%), Rockland Trust Co. (0.01%) and IFM Investors Pty Ltd (0.01%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin. View institutional ownership trends for Varian Medical Systems.

Which major investors are selling Varian Medical Systems stock?

VAR stock was sold by a variety of institutional investors in the last quarter, including IFM Investors Pty Ltd, Exchange Traded Concepts LLC, Wesbanco Bank Inc., Thomasville National Bank, Nelson Van Denburg & Campbell Wealth Management Group LLC, and MA Private Wealth. Company insiders that have sold Varian Medical Systems company stock in the last year include Christopher A Toth, Dow R Wilson, John W Kuo, Kolleen T Kennedy, Magnus Momsen, and R Andrew Eckert. View insider buying and selling activity for Varian Medical Systems.

Which major investors are buying Varian Medical Systems stock?

VAR stock was purchased by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Canandaigua National Corp, Everence Capital Management Inc., Stock Yards Bank & Trust Co., Carnegie Capital Asset Management LLC, Cypress Capital Group, DNB Asset Management AS, and Envestnet Asset Management Inc.. View insider buying and selling activity for Varian Medical Systems.

How do I buy shares of Varian Medical Systems?

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of VAR stock can currently be purchased for approximately $125.52.

How big of a company is Varian Medical Systems?

Varian Medical Systems has a market capitalization of $11.40 billion and generates $3.23 billion in revenue each year. The medical equipment provider earns $291.90 million in net income (profit) each year or $4.63 on an earnings per share basis. Varian Medical Systems employs 10,062 workers across the globe.

What is Varian Medical Systems' official website?

The official website for Varian Medical Systems is www.varian.com.

How can I contact Varian Medical Systems?

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]

This page was last updated on 7/16/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.